ArticleFrontiers in oncology2021

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report.

Romain Varnier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.